Nothing Special   »   [go: up one dir, main page]

Hypopituitarism - Thomas

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 40
At a glance
Powered by AI
The document discusses hypopituitarism which is a deficiency of one or more hormones produced by the pituitary gland. It can be caused by tumors, injuries, genetic conditions, and other factors and presents with a variety of non-specific symptoms depending on the hormone affected.

Hypopituitarism can be caused by tumors of the pituitary or hypothalamus, traumatic brain injuries, subarachnoid hemorrhage, genetic conditions, infiltrative disorders, and other factors mentioned on pages 1-3.

Clinical manifestations of hypopituitarism depend on the hormone affected and can include fatigue, weight changes, menstrual irregularities, electrolyte abnormalities, and other signs mentioned on pages 27-28.

Hasan AYDIN, MD

Endocrinology and Metabolism


Yeditepe University Medical Faculty
 The deficiency (hypo) of one or more hormones
of the pituitary gland
 Deficiency of one or multiple hormones of the
anterior pituitary …….-hypopituitarism
 Deficiency of the posterior lobe …..-central
diabetes insipitus
 Deficiency of all pituitary hormones….-
panhypopituitarism
 Either result from hypothalamus or pituitary

 Symptoms and signs frequently protean and


nonspecific
 Abnormalities in electrolyte levels,
 Altered mental status,
 Abnormal glucose levels,
 Altered body temperature,
 Increased heart rate

 Patients at risk of developing hypopituitarism


 Traumatic brain injury (TBI),
 Cocaine use,
 Subarachnoid hemorrhage,
 Postpartum hypotension (Sheehan syndrome).
 76% tumor or treatment of tumor
 Mass effect of adenoma on other hormones
 Surgical resection of non-adenomatous tissue
 Radiation of pituitary

 13% extrapituitary tumor


 Craniopharyngioma

 8% unknown

 1% sarcoidosis

 0.5% Sheehan’s syndrome


 In US
 Prevelance of pituitary adenoma 10-20%
 Hypopituitarism 2-8/100,000 persons/year
 World
 Incidence of 4.2 cases per 100,000 per year
 Prevalence of 45.5 per 100,000 without gender
difference
 Missed or delayed diagnosis could potentially lead to
permanent disability or death

 Female patients with hypopituitarism have more


than a 2-fold increase in cardiovascular mortality

 Cardiovascular disease is significantly higher among


hypopituitary patients (incidence ratio, 3.7; 95%
confidence interval)

 Hypopituitary patients have lower high-density


lipoprotein cholesterol and higher low-density/high-
density lipoprotein ratio
 Primary pituitary disease  Interruption of the
 Tumors pituitary stalk
 Pituitary surgery
 Radiation treatment
 Extrasellar disorders
 Hypothalamic
 Craniopharyngioma
disease  Rathke pouch
 Functional suppression of axis
 Exogenous steroid use
 Extreme weight loss
 Exercise
 Systemic Illness
 Developmental and  Acquired causes:
genetic causes  Infiltrative disorders
 Dysplasia  Cranial irradiation
 Septo-Optic dysplasia  Lymphocytic hypophysitis
 Developmental  Pituitary Apoplexy
hypothalamic dysfunction  Empty Sella syndrome
 Kallman Syndrome
 Laurence-Moon-Bardet-
Biedl Syndrome
 Frohlich Syndrome (Adipose
Genital Dystrophy)
 Hypothalamic dysfunction and hypopituitarism
 may result from dysgenesis of the septum pellucidum or
corpus callosum

 Affected children have mutations in the HESX1 gene

 These children exhibit variable combinations of:


 cleft palate
 syndactyly
 ear deformities
 optic atrophy
 micropenis
 anosmia
 Pituitary dysfunction
 Diabetes insipidus
 GH deficiency and short stature
 Occasionally TSH deficiency
 Defective hypothalamic gonadotropin-releasing
hormone (GnRH) synthesis

 Associated with anosmia or hyposmia due to olfactory


bulb agenesis or hypoplasia

 May also be associated with: color blindness,


optic atrophy, nerve deafness, cleft palate,
renal abnormalities, cryptorchidism

 GnRH deficiency prevents progression


through puberty

 Characterized by
 low LH and FSH levels
 low concentrations of sex steroids
 Males patients
 Delayed puberty and hypogonadism, including micropenis
 Long-term treatment:
 human chorionic gonadotropin (hCG) or testosterone

 Female patients
 Primary amenorrhea and failure of secondary sexual
development
 Long-term treatment:
 cyclic estrogen and progestin

 Repetitive GnRH administration restores normal puberty

 Fertility may also be restored by the administration of


gonadotropins or by using a portable infusion pump to
deliver subcutaneous, pulsatile GnRH
 Rare autosomal recessive disorder

 Characterized by mental retardation; obesity;


hexadactyly, brachydactyly, or syndactyly

 Central diabetes insipidus may or may not be


associated

 GnRH deficiency occurs in 75% of males and half of


affected females

 Retinal degeneration begins in early childhood


 most patients are blind by age 30
 A broad spectrum of hypothalamic lesions
 hyperphagia, obesity, and central hypogonadism

 Decreased GnRH production in these patients results in


 attenuated pituitary FSH and LH synthesis and release

 Deficiencies of leptin, or its receptor, cause these clinical


features
 Infiltrative disorders

 Cranial irradiation

 Lymphocytic hypophysitis

 Pituitary Apoplexy

 Empty Sella syndrome


 Etiology
 Presumed to be autoimmune
 Clinical Presentation
 Women, during postpartum period
 Mass effect (sellar mass)
 Deficiency of one or more anterior pituitary hormones
 ACTH deficiency is the most common
 Diagnosis
 MRI - may be indistinguishable from pituitary adenoma
 Treatment
 Corticosteroids – often not effective
 Hormone replacement
Patoloji Radyoloji
 Hemorrhagic infarction of a pituitary
adenoma/tumor
 Considered a neurosurgical emergency
 Presentation:
 Variable onset of severe headache
 Nausea and vomiting
 Meningismus
 Vertigo
 +/ - Visual defects
 +/ - Altered consciousness
 Symptoms may occur immediately or may develop
over 1-2 days
 Risk factors:
 Diabetes
 Radiation treatment
 Warfarin use
 Usually resolve completely
 Transient or permanent hypopituitarism is possible
 undiagnosed acute adrenal insufficiency
 Diagnose with CT/MRI
 Differentiate from leaking aneurysm
 Treatment:
 Surgical - Transsphenoid decompression
 Visual defects and altered consciousness
 Medical therapy – if symptoms are mild
 Corticosteroids
Radiology
 Infarction of pituitary after substantial blood loss
during childbirth

 Incidence: 3.6%

 No correlation between severity of hemorrhage and


symptoms

 Severe: recognised days to weeks PP


 Lethargy, anorexia, weight loss, unable to breast feeding
 Typically long interval between obstetric event and
diagnosis

 Of 25 cases studied:

 50% permanent amenorrhea

 The rest had scanty-rare menses

 Most lactation was poor to absent

 Dx: MRI empty sella turcica


Often an incidental MRI finding
  Usually have normal pituitary function
 Implying that the surrounding rim of pituitary tissue is fully
functional

 Hypopituitarism may develop insidiously

 Pituitary
masses may undergo clinically silent infarction
with development of a partial or totally empty sella by
cerebrospinal fluid (CSF) filling the dural herniation.

 Rarely, functional pituitary adenomas may arise within


the rim of pituitary tissue, and these are not always
visible on MRI
 Can present with features of deficiency of one or
more anterior pituitary hormones

 Clinical presentation depends on:

 Age at onset

 Hormone affected, extent

 Speed of onset

 Duration of the deficiency


Radiology
Women Men
 Oligomenorrhea or  Loss of libido
amenorrhea
 Erectile dysfunction
 Loss of libido
 Infertility
 Vaginal dryness or
dyspareunia  Loss of secondary sex
characteristics
 Loss of secondary sex  Atrophy of the testes
characteristics (estrogen
deficiency)  Gynecomastia (testosterone
deficiency)
 Results in hypocortisolism
 Malaise
 Anorexia
 Weight-loss
 Gastrointestinal disturbances
 Hyponatremia

 Pale complexion
 Unable to tan or maintain a tan

 No features of mineralocorticoid deficiency


 Aldosterone secretion unaffected
 Hypothyroidism

 Atrophic thyroid gland


 Inability to lactate postpartum

 Often 1st manifestation of Sheehan syndrome


 Adults
 Often asymptomatic

 May complain of
 Fatigue
 Degrees exercise tolerance
 Abdominal obesity
 Loss of muscle mass

 Children
 GH Deficiency

 Constitutional growth delay


 Biochemical diagnosis of pituitary
insufficiency

 Demonstrating low levels of trophic hormones in


the setting of low target hormone levels

 Provocative tests may be required to assess


pituitary reserve
 Basal ACTH secretion
 Cortisol < 3 μg/dL, cortisol deficiency
 Cortisol > 18μg/dL, sufficient ACTH
 Cortisol > 3 μd/dL but < 18 μg/dL - test ACTH reserve

 ACTH reserve
 Metyrapone test (750 mg q 4hr for 24 hrs)
 Cortisol < 7 μg/dL, 11-deoxycortisol > 10 μg/dL
 ITT ( 0.1 U/kg BW)
 Cortisol > 18 μg/dL, normal
 Cosyntropin stimulation test
 Cortisol > 18 μg/dL, normal
 Serum T4 should be measured

 TSH may not be helpful


 MEN

 Testosterone low, LH normal or low

 Sperm count

 WOMEN

 LH-FSH,
E2, vaginal cytology, response to
medroxyprogesterone 10 mg qd for 10 days
 Peak GH response < 5 ng/ml
 ITT

 Arginine ( 0.5 g/ kgBW i.v.)

 L-DOPA ( 0.5 g orally )

 Clonidine ( 0.15 mg orally )

 Glucagon ( 0.03 μg/kg BW s.c. + 40 mg propranolol )


 Cortisol deficiency ( 5 - 2.5 mg prednisone qd)

 Levothyroxine ( 0.075 -0.15 mg qd )

 Gonadal steroids (E2 ,P, Testosterone)

 Growth hormone

 Vasopressin (desmopressin 10 μg x 2)
 Hormone replacement therapy

 usually free of complications

 Treatment regimens that mimic physiologic


hormone production

 allow
for maintenance of satisfactory clinical
homeostasis

You might also like